Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026

$LCTXPress releaseJul 30, 2026, 8:00 AM ETRead the release

Lineage Cell Therapeutics announced it will report its second quarter 2026 financial results on August 6, 2026, after the market closes. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide a business update.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.